Esophageal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Esophageal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: Conversion of Tislelizumab Combined With Chemotherapy in Unresectable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial updating the use of tislelizumab in combination with chemotherapy for unresectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab combined with palliative radiation therapy in patients with metastatic cancers of the esophagus, st…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC [Phase 2, Phase 3]
A phase 2/3 clinical trial is evaluating neoadjuvant immunotherapy plus chemoradiation versus neoadjuvant chemoradiation for locally advance…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus [Phase 2]
Phase 2 trial evaluating short-course neoadjuvant chemo-radiotherapy plus toripalimab for locoregionally advanced resectable esophageal squa…
-
CLINICAL_TRIALS trial_result · 2022-06-15Clinical Trial Update: Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC [Phase 2, Phase 3]
Clinical trial update for neoadjuvant nivolumab or placebo plus chemotherapy followed by surgery and adjuvant treatment in resectable esopha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma [Phase 2]
Phase 2 trial update evaluating neoadjuvant SHR-1316 immunoreagent for resectable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Comparing Paclitaxel/Cisplatin and Cisplatin/5-fluorouracil in Neo-CRT for ESCC [Phase 2, Phase 3]
A phase 2/3 trial comparing paclitaxel/cisplatin versus cisplatin/5-fluorouracil in neoadjuvant chemoradiation for esophageal squamous cell …
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) [Phase 3]
Phase 3 trial comparing pembrolizumab plus neoadjuvant chemotherapy to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous…
-
CLINICAL_TRIALS trial_result · 2022-05-27Clinical Trial Update: Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC [Phase 1, Phase 2]
Phase 1/2 trial evaluating chemoradiation plus tislelizumab for conversion therapy in locally nonresectable esophageal squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study [Phase 2]
A Phase 2 randomized trial comparing esophageal arterial infusion chemotherapy to systemic intravenous chemotherapy in resectable locally ad…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma. [Phase 1, Phase 2]
A clinical trial update for an anti-PD-L1 antibody combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma (Phase 1/Pha…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer [Phase 2]
Phase II trial update evaluating camrelizumab with chemotherapy or anlotinib in advanced esophageal squamous cell carcinoma (Stage IV).
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating nivolumab as immune checkpoint therapy for esophageal squamous cell carcinoma; the study status is terminated w…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial update on neoadjuvant chemotherapy with nab-paclitaxel, cisplatin, and capecitabine for locally advanced thoracic esophageal s…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade [Phase 2]
Phase 2 trial evaluating decitabine in combination with penpulimab as second-line therapy for advanced esophageal squamous cell carcinoma af…
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC [Phase 2]
Phase II trial evaluating SHR-1210 with preoperative chemotherapy or apatinib for locally advanced esophageal squamous cell carcinoma is in …
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer [Phase 3]
Phase 3 trial comparing paclitaxel-based regimens with radiotherapy in locally advanced esophageal squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating neoadjuvant chemotherapy with a PD-1 monoclonal antibody for operable esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. [Phase 2]
Phase 2 trial update investigating neoadjuvant treatment for locally advanced thoracic esophageal squamous cell carcinoma using camrelizumab…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial exploring a PD-1 inhibitor combined with neoadjuvant chemotherapy in resectable locally advanced thoracic esophageal …
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma [Phase 1, Phase 2]
A clinical trial update on camrelizumab combined with neoadjuvant chemotherapy for resectable thoracic esophageal squamous cell carcinoma sp…
-
CLINICAL_TRIALS trial_result · 2021-12-13Clinical Trial Update: The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating toripalimab (JS001) in advanced gastric cancer and multiple squamous cell carcinomas including esophagea…
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Neo-NTP-CRT for Locally Advanced ESCC [Phase 2]
Phase 2 trial update for Neo-NTP-CRT in locally advanced esophageal squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy, chemoradiotherapy, and surgery alone for pN1-2 (pT1b-3N1-2M0) esophageal carcinoma is curre…